Immunizations

Citations

1. Parker SK, et al. (2004). Thimerosal-containing vaccines and autistic spectrum disorder: A critical review of published original data. Pediatrics 114(3): 793–804.

2. Centers for Disease Control and Prevention (2009). Vaccine safety: Mercury and thimerosal. Available online: http://www.cdc.gov/vaccinesafety/concerns/thimerosal/index.html.

3. Demicheli V, et al. (2005). Vaccines for measles, mumps and rubella in children. Cochrane Database of Systematic Reviews (4). Oxford: Update Software.

4. Peacock G, Yeargin-Allsopp M (2009). Autism spectrum disorders: Prevalence and vaccines. Pediatric Annals, 38(1): 22–25.

5. Centers for Disease Control and Prevention (2011). Recommended immunization schedules for persons aged 0 through 18 years—United States, 2011. MMWR, 60(05): 1–4. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6005a6.htm?s_cid=mm6005a6_e&source=govdelivery. [Erratum in MMWR, 60(RR-10): 315. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6010a6.htm?s_cid=mm6010a6_e&source=govdelivery.]

6. Centers for Disease Control and Prevention (2011). Prevention and control of influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. MMWR, 60(Early Release): 1–6. Also available online: http://www.cdc.gov/mmwr/pdf/wk/mm60e0818.pdf?source=govdelivery.

7. Centers for Disease Control and Prevention (2009). Updated recommendations from the Advisory Committee on Immunization Practices (ACIP) for use of hepatitis A vaccine in close contacts of newly arriving international adoptees. MMWR, 58(36): 1006–1007. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5836a4.htm?s_cid=mm5836a4_e.

8. Centers for Disease Control and Prevention. (2011). Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book), 12th ed. Washington, DC: Public Health Foundation. Also available online: http://www.cdc.gov/vaccines/pubs/pinkbook/default.htm.

9. Centers for Disease Control and Prevention (2011). Recommended adult immunization schedule—United States, 2011. MMWR, 60(04): 1–4. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6004a10.htm?s_cid=mm6004a10_e&source=govdelivery.

10. Centers for Disease Control and Prevention (2010). Licensure of a high-dose inactivated influenza vaccine for persons aged =65 years (Fluzone high-dose) and guidance for use—United States, 2010. MMWR, 59(16): 485–486. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5916a2.htm?s_cid=mm5916a2_e.

11. Centers for Disease Control and Prevention (1998, updated 2007). Guidelines for Vaccinating Pregnant Women From Recommendations of the Advisory Committee on Immunization Practices (ACIP). Available online: http://www.cdc.gov/vaccines/pubs/preg-guide.htm.

12. U.S. Food and Drug Administration (2007). FDA approves first U.S. vaccine for humans against the avian influenza virus H5N1. FDA News. Available online: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108892.htm.

13. Mitka M (2007). Bioterror vaccine production: Take 2. JAMA, 297(6): 575–576.

14. Centers for Disease Control and Prevention (2007). Smallpox fact sheet: Vaccine overview. Available online: http://emergency.cdc.gov/agent/smallpox/vaccination/facts.asp.

Other Works Consulted

• Centers for Disease Control and Prevention (2005). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States, Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part 1: Immunization of infants, children, and adolescents. MMWR, 54(RR-16): 1–23. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5416a1.htm. [Erratum in MMWR, 55(06): 158–159. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5506a6.htm.]

• Centers for Disease Control and Prevention (2005). Prevention and control of meningococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 54(RR-7): 1–21. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5407a1.htm.

• Centers for Disease Control and Prevention (2006). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States, Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: Immunization of adults. MMWR, 55(RR-16): 1–33. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5516a1.htm. [Erratum in MMWR, 56(42): 1114.]

• Centers for Disease Control and Prevention (2006). Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 55 (RR-7): 1–23. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr5507.pdf.

• Centers for Disease Control and Prevention (2007). Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 56(RR-4): 1–48. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr5604.pdf.

• Centers for Disease Control and Prevention (2008). Prevention of herpes zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 57(05): 1–30. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5705a1.htm. [Erratum in MMWR, 57(28): 779. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5728a5.htm.]

• Centers for Disease Control and Prevention (2008). Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 57(RR-4): 1–51. [Erratum in MMWR, 57(26): 723. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5726a3.htm.]

• Centers for Disease Control and Prevention (2008). Syncope after vaccination: United States, January 2005 to July 2007. MMWR, 57(17): 457–460.

• Centers for Disease Control and Prevention (2009). Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease. MMWR, 58(37): 1042–1043. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5837a4.htm?s_cid=mm5837a4_e.

• Centers for Disease Control and Prevention (2010). Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR, 59(34): 1102–1106. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5934a3.htm?s_cid=mm5934a3_e.

• Centers for Disease Control and Prevention (2010). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR, 59(20): 626–629. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5920a4.htm?s_cid=mm5920a4_e.

• Centers for Disease Control and Prevention (2010). FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR, 59(20): 630–632. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5920a5.htm?s_cid=mm5920a5_e.

• Centers for Disease Control and Prevention (2010). Prevention of pneumococcal disease among infants and children: Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 59(RR-11): 1–18. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr5911.pdf.

• Centers for Disease Control and Prevention (2010). Use of combination measles, mumps, rubella, and varicella vaccine. MMWR, 59(03): 1–12. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5903a1.htm?s_cid=rr5903a1_e.

• Centers for Disease Control and Prevention (2011). Licensure of a meningococcal conjugate vaccine for children aged 2 through 10 years and updated booster dose guidance for adolescents and other persons at increased risk for meningococcal disease—Advisory Committee on Immunization Practices (ACIP), 2011. MMWR, 60(30): 1018–1019. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6030a3.htm?s_cid=mm6030a3_e&source=govdelivery.

• Centers for Disease Control and Prevention (2011). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR, 60(01): 13–15. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6001a4.htm?s_cid=mm6001a4_w.

• Moberley S, et al. (2008). Vaccines for preventing pneumococcal infection in adults. Cochrane Database of Systematic Reviews (1).

• Orenstein WA, et al. (2008). Diseases controlled primarily by vaccination. In RB Wallace, ed., Wallace/Maxcy-Rosenau-Last Public Health and Preventive Medicine, 15th ed., pp. 101–153. New York: McGraw-Hill.

• Orenstein WA, Pickering LK (2007). Immunization practices. In RM Kliegman et al., eds., Nelson Textbook of Pediatrics, 18th ed., pp. 1058–1070. Philadelphia: Saunders Elsevier.

• Thompson WW, et al. (2007). Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. New England Journal of Medicine, 357(13): 1281–1292.

• U.S. Department of Health and Human Services (2009). Prevention of rotavirus gastroenteritis among infants and children: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 58(RR-2): 1–25. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr5802.pdf. [Erratum in MMWR, 59(33): 1074.]

• Weller PF (2009). Health advice for international travelers. In EG Nabel, ed., ACP Medicine, Clinical Essentials, chap. 7. Hamilton, ON: BC Decker.